Skip to main content
Delfa

Lead sponsor

University Hospital, Basel, Switzerland

11 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.

11

Trials led

0

Ongoing

591

Total enrollment

3

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 1
1
Phase 2
4
Not applicable
6

Trials by status

Completed
11

Trials led

SKIPBMI 18-30Ph 2Completed256
Desire PLUSBMI ≥27not applicableCompleted85
New Imaging Procedure for the Localisation of Insulinoma-not applicableCompleted52
GOLD-Ph 2Completed50
Whole Body 111In-exendin-4 Imaging Study in Insulinoma Patients-not applicableCompleted30
FAST-not applicableCompleted29
DESIREBMI 18.5-25Ph 2Completed26
PIANOBMI 18.5-30not applicableCompleted22
GATE-Ph 2Completed17
Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in HumansBMI 19-25Ph 1Completed12
The Role of Endogenous GLP-1 (Glycolipoprotein) in Regulating Glucose Stimulated Brain ActivityMale · Healthy volunteersnot applicableCompleted12